All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Acute Pancreatitis Secondary to Marijuana Consumption

Laura Nunez Herrero, Benjamin Chaucer, Shiwani Singh, Vrushak Deshpande and Sunil H Patel

Richmond University Medical Center, Department of Internal Medicine, Staten Island, NY 10310, United States

*Corresponding Author:
Benjamin Chaucer
Department of Internal Medicine
400 Forest Avenue
Apt 2r
Staten Island, New York 10301
United States
Phone: +1 473-444-4175
E-mail: [email protected]

Received December 30th, 2015-Accepted February 03rd, 2016

 
Visit for more related articles at JOP. Journal of the Pancreas

Abstract

Acute pancreatitis is a common disease with many well-known etiologies. Rare causes of pancreatitis are still being discovered. We present the 13th reported case of marijuana induced acute pancreatitis. The role of marijuana in pancreatitis is not clearly defined. Studies have begun to clarify the role that cannabinoids may play in this disease process. This case demonstrates the need for further research.

Keywords

Pancreas; Pancreatitis

INTRODUCTION

Acute pancreatitis is a serious disease with a mortality rate as high as 20%. Common causes of acute pancreatitis include, alcohol, obstruction and drug side effect. Marijuana has been documented as a rare cause of acute pancreatitis. While the pathophysiology of this disease process is not yet proven reports of its occurrence have increased in the last decade. This increase in reported cases of acute pancreatitis in conjunction with local legalization of medical and recreational marijuana use make this case of particular importance. We report the 13th case of cannabis induced acute pancreatitis worldwide and the 4th in the United States.

CASE REPORT

A thirty-year-old male presented to the emergency department with a chief complaint of severe abdominal pain. He described the pain as stabbing, non radiating pain that he rated as 10/10. The pain had occurred for a 1 day duration and was associated with nausea and vomiting. Physical examination was positive for tenderness in the abdomen to light palpation. Laboratory evaluation was positive for an elevated lipase of 4218 U/L. Ultrasound was performed to rule out obstruction. Computed tomography (CT) subsequently performed showed no anatomical abnormalities. Alcohol, biliary, medication and infectious causes were excluded. A urine toxicology screen was done revealing a urinary drug screen positive for tetrahydrocannabinol (THC). After further questioning, he admitted to consistent user of copious amounts of marijuana. The patient was made NPO and IV fluids were started with a peripheral line. Clinical improvement was achieved with supportive treatment. After resolution of symptoms the patient was counseled on the dangers of illicit drug use and discharged home.

DISCUSSION

Marijuana has been used for centuries in native medicine for the treatment of several health problems [1]. Adverse effects associated with the chronic use of cannabis include infertility, erectile dysfunction, visual disorders and schizophrenia [2]. Pancreatitis is one of the least reported complications, with only 12 reported cases of cannabis-induced pancreatitis [2-11]. Well know causes of acute pancreatitis include obstruction, alcohol consumption and drug use. Of these, obstruction and alcohol represent 70-80% of cases. The reporting of drug induced acute pancreatitis is challenging. Data about this pathology is dependent on physician reporting. This diagnosis is further compounded by the frequent use of polypharmacy making the specific offending agent difficult to pinpoint. The true incidence of cannabis-induced pancreatitis may therefore be underestimated. The financial and public health importance of acute pancreatitis is evident with 25% of acute pancreatitis cases resulting in an Intensive Care Unit stay [12].

Cannabis induced acute pancreatitis has only been reported 12 times in current literature. Of these, 2 resulted in chronic pancreatitis. The first documented case occurred as recently as 2004 [3]. In order to diagnosis cannabis induced pancreatitis, all other causes must be excluded. Interestingly in all documented cases chronic consumption was reported by each patient.

Reasons for the increase in reported cases are multifaceted. Marijuana is the most widely used illicit drug worldwide. Marijuana use has increase from 5.8% of people in the US above 12 years of age using marijuana in 2007 to 7.5% of the US population in 2013 [13]. This increase in the use of marijuana may in part explain the increased incidence of cannabis-induced pancreatitis. Cannabis was not previously thought to play a role in the etiology of acute pancreatitis. As more cases come to light we may see an increase in this diagnosis. Marijuana induced pancreatitis may represent a percentage of acute pancreatitis previously diagnosed as idiopathic. The difficulty of this diagnosis is further compounded by the legal status of this substance. Patients may feel resistant to divulge illegal drug use, making urine toxicology screening essential in its diagnosis.

The pathophysiology of marijuana-induced pancreatitis is not understood. Studies aimed at understanding this mechanism have begun to explain the role of cannabanoids in acute pancreatitis. The active component in marijuana is tetrahydrocannabinol (THC), which acts on cannabinoid receptors CB1 and CB2. Several compounds target these receptors know as cannabinoids. The CB1 receptor is found in the smooth muscle of blood vessels, endothelial cells and nervous system and is responsible for many of the symptoms associated with marijuana intoxication [14]. CB2 receptors are found on blood and immune cells [15]. Both CB1 and CB2 are present in the islet of Langerhans cells of the human pancreas [16]. In the pancreas, effect of cannabinoid on the course of pancreatitis is not clarified [1]. Ananadamide (arachidonylethanolamide) is produced my macrophages and is an endocanabanoid [17]. This works as an endogenous ligand of the CB1 receptor. A recent study showed that endocannabonoids may play a role in septic shock and that therapy targeted at removal of these compounds may improve outcomes [18]. In one study by Kazuhisa et al. levels of plasma anandamide was significantly elevated after induction of sever acute pancreatitis in a rat experimental model [19]. Another study done in 2008, showed that the effect of cannabinoids on pancreatitis may depend on the time of administration [1]. Treatment with anandamine prior to induction of pancreatitis aggravated pancreatic damage, while its administration after induction of pancreatitis reduced the severity of the disease. It is important to note that in all reported cases of cannabis induced acute pancreatitis excessive cannabis use was reported [2-12].

Data is lacking regarding the pathophysiology and role of cannabis in acute pancreatitis. While the role of marijuana in acute pancreatitis is not yet defined it remains an important differential in cases without a clear etiology. As such urine toxicology screen should be part of the laboratory work up for all idiopathic cases of acute pancreatitis.

Acknowledgement

We would like to thank and acknowledge Dr. Dennis Bloomfield for his help and support.

Conflict of interest

The authors declare that there are no conflicts of interest.

References

Select your language of interest to view the total content in your interested language

Viewing options

Post your comment

Share This Article

Flyer image
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh